1 H3N2 Infection Treatment Market Overview 1.1 Product Overview and Scope of H3N2 Infection Treatment 1.2 H3N2 Infection Treatment Segment by Type 1.2.1 Global H3N2 Infection Treatment Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 APP-309 1.2.3 Aspidasept 1.2.4 C-05 1.2.5 CR-8020 1.2.6 Others 1.3 H3N2 Infection Treatment Segment by Application 1.3.1 H3N2 Infection Treatment Sales Comparison by Application: (2021-2027) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global H3N2 Infection Treatment Market Size Estimates and Forecasts 1.4.1 Global H3N2 Infection Treatment Revenue 2016-2027 1.4.2 Global H3N2 Infection Treatment Sales 2016-2027 1.4.3 H3N2 Infection Treatment Market Size by Region: 2016 Versus 2021 Versus 2027 2 H3N2 Infection Treatment Market Competition by Manufacturers 2.1 Global H3N2 Infection Treatment Sales Market Share by Manufacturers (2016-2021) 2.2 Global H3N2 Infection Treatment Revenue Market Share by Manufacturers (2016-2021) 2.3 Global H3N2 Infection Treatment Average Price by Manufacturers (2016-2021) 2.4 Manufacturers H3N2 Infection Treatment Manufacturing Sites, Area Served, Product Type 2.5 H3N2 Infection Treatment Market Competitive Situation and Trends 2.5.1 H3N2 Infection Treatment Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest H3N2 Infection Treatment Players Market Share by Revenue 2.5.3 Global H3N2 Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 H3N2 Infection Treatment Retrospective Market Scenario by Region 3.1 Global H3N2 Infection Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global H3N2 Infection Treatment Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America H3N2 Infection Treatment Market Facts & Figures by Country 3.3.1 North America H3N2 Infection Treatment Sales by Country 3.3.2 North America H3N2 Infection Treatment Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe H3N2 Infection Treatment Market Facts & Figures by Country 3.4.1 Europe H3N2 Infection Treatment Sales by Country 3.4.2 Europe H3N2 Infection Treatment Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific H3N2 Infection Treatment Market Facts & Figures by Region 3.5.1 Asia Pacific H3N2 Infection Treatment Sales by Region 3.5.2 Asia Pacific H3N2 Infection Treatment Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America H3N2 Infection Treatment Market Facts & Figures by Country 3.6.1 Latin America H3N2 Infection Treatment Sales by Country 3.6.2 Latin America H3N2 Infection Treatment Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa H3N2 Infection Treatment Market Facts & Figures by Country 3.7.1 Middle East and Africa H3N2 Infection Treatment Sales by Country 3.7.2 Middle East and Africa H3N2 Infection Treatment Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global H3N2 Infection Treatment Historic Market Analysis by Type 4.1 Global H3N2 Infection Treatment Sales Market Share by Type (2016-2021) 4.2 Global H3N2 Infection Treatment Revenue Market Share by Type (2016-2021) 4.3 Global H3N2 Infection Treatment Price by Type (2016-2021) 5 Global H3N2 Infection Treatment Historic Market Analysis by Application 5.1 Global H3N2 Infection Treatment Sales Market Share by Application (2016-2021) 5.2 Global H3N2 Infection Treatment Revenue Market Share by Application (2016-2021) 5.3 Global H3N2 Infection Treatment Price by Application (2016-2021) 6 Key Companies Profiled 6.1 AIMM Therapeutics B.V. 6.1.1 AIMM Therapeutics B.V. Corporation Information 6.1.2 AIMM Therapeutics B.V. Description and Business Overview 6.1.3 AIMM Therapeutics B.V. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.1.4 AIMM Therapeutics B.V. Product Portfolio 6.1.5 AIMM Therapeutics B.V. Recent Developments/Updates 6.2 Aphios Corporation 6.2.1 Aphios Corporation Corporation Information 6.2.2 Aphios Corporation Description and Business Overview 6.2.3 Aphios Corporation H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Aphios Corporation Product Portfolio 6.2.5 Aphios Corporation Recent Developments/Updates 6.3 Crucell N.V. 6.3.1 Crucell N.V. Corporation Information 6.3.2 Crucell N.V. Description and Business Overview 6.3.3 Crucell N.V. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Crucell N.V. Product Portfolio 6.3.5 Crucell N.V. Recent Developments/Updates 6.4 CSL Limited 6.4.1 CSL Limited Corporation Information 6.4.2 CSL Limited Description and Business Overview 6.4.3 CSL Limited H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 CSL Limited Product Portfolio 6.4.5 CSL Limited Recent Developments/Updates 6.5 Glide Pharmaceutical Technologies Limited 6.5.1 Glide Pharmaceutical Technologies Limited Corporation Information 6.5.2 Glide Pharmaceutical Technologies Limited Description and Business Overview 6.5.3 Glide Pharmaceutical Technologies Limited H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Glide Pharmaceutical Technologies Limited Product Portfolio 6.5.5 Glide Pharmaceutical Technologies Limited Recent Developments/Updates 6.6 ILiAD Biotechnologies, LLC 6.6.1 ILiAD Biotechnologies, LLC Corporation Information 6.6.2 ILiAD Biotechnologies, LLC Description and Business Overview 6.6.3 ILiAD Biotechnologies, LLC H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.6.4 ILiAD Biotechnologies, LLC Product Portfolio 6.6.5 ILiAD Biotechnologies, LLC Recent Developments/Updates 6.7 Inovio Pharmaceuticals, Inc. 6.6.1 Inovio Pharmaceuticals, Inc. Corporation Information 6.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview 6.6.3 Inovio Pharmaceuticals, Inc. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Inovio Pharmaceuticals, Inc. Product Portfolio 6.7.5 Inovio Pharmaceuticals, Inc. Recent Developments/Updates 6.8 Johnson & Johnson 6.8.1 Johnson & Johnson Corporation Information 6.8.2 Johnson & Johnson Description and Business Overview 6.8.3 Johnson & Johnson H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Johnson & Johnson Product Portfolio 6.8.5 Johnson & Johnson Recent Developments/Updates 6.9 Medicago Inc. 6.9.1 Medicago Inc. Corporation Information 6.9.2 Medicago Inc. Description and Business Overview 6.9.3 Medicago Inc. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Medicago Inc. Product Portfolio 6.9.5 Medicago Inc. Recent Developments/Updates 6.10 MedImmune, LLC 6.10.1 MedImmune, LLC Corporation Information 6.10.2 MedImmune, LLC Description and Business Overview 6.10.3 MedImmune, LLC H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.10.4 MedImmune, LLC Product Portfolio 6.10.5 MedImmune, LLC Recent Developments/Updates 6.11 Mucosis B.V. 6.11.1 Mucosis B.V. Corporation Information 6.11.2 Mucosis B.V. H3N2 Infection Treatment Description and Business Overview 6.11.3 Mucosis B.V. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Mucosis B.V. Product Portfolio 6.11.5 Mucosis B.V. Recent Developments/Updates 6.12 NanoViricides, Inc. 6.12.1 NanoViricides, Inc. Corporation Information 6.12.2 NanoViricides, Inc. H3N2 Infection Treatment Description and Business Overview 6.12.3 NanoViricides, Inc. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.12.4 NanoViricides, Inc. Product Portfolio 6.12.5 NanoViricides, Inc. Recent Developments/Updates 6.13 Novavax, Inc. 6.13.1 Novavax, Inc. Corporation Information 6.13.2 Novavax, Inc. H3N2 Infection Treatment Description and Business Overview 6.13.3 Novavax, Inc. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.13.4 Novavax, Inc. Product Portfolio 6.13.5 Novavax, Inc. Recent Developments/Updates 6.14 OPKO Health, Inc. 6.14.1 OPKO Health, Inc. Corporation Information 6.14.2 OPKO Health, Inc. H3N2 Infection Treatment Description and Business Overview 6.14.3 OPKO Health, Inc. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.14.4 OPKO Health, Inc. Product Portfolio 6.14.5 OPKO Health, Inc. Recent Developments/Updates 6.15 Sarepta Therapeutics, Inc. 6.15.1 Sarepta Therapeutics, Inc. Corporation Information 6.15.2 Sarepta Therapeutics, Inc. H3N2 Infection Treatment Description and Business Overview 6.15.3 Sarepta Therapeutics, Inc. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.15.4 Sarepta Therapeutics, Inc. Product Portfolio 6.15.5 Sarepta Therapeutics, Inc. Recent Developments/Updates 6.16 Takeda Pharmaceutical Company Limited 6.16.1 Takeda Pharmaceutical Company Limited Corporation Information 6.16.2 Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Description and Business Overview 6.16.3 Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.16.4 Takeda Pharmaceutical Company Limited Product Portfolio 6.16.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates 6.17 Visterra, Inc. 6.17.1 Visterra, Inc. Corporation Information 6.17.2 Visterra, Inc. H3N2 Infection Treatment Description and Business Overview 6.17.3 Visterra, Inc. H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.17.4 Visterra, Inc. Product Portfolio 6.17.5 Visterra, Inc. Recent Developments/Updates 6.18 Zydus Cadila Healthcare Limited 6.18.1 Zydus Cadila Healthcare Limited Corporation Information 6.18.2 Zydus Cadila Healthcare Limited H3N2 Infection Treatment Description and Business Overview 6.18.3 Zydus Cadila Healthcare Limited H3N2 Infection Treatment Sales, Revenue and Gross Margin (2016-2021) 6.18.4 Zydus Cadila Healthcare Limited Product Portfolio 6.18.5 Zydus Cadila Healthcare Limited Recent Developments/Updates 7 H3N2 Infection Treatment Manufacturing Cost Analysis 7.1 H3N2 Infection Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of H3N2 Infection Treatment 7.4 H3N2 Infection Treatment Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 H3N2 Infection Treatment Distributors List 8.3 H3N2 Infection Treatment Customers 9 H3N2 Infection Treatment Market Dynamics 9.1 H3N2 Infection Treatment Industry Trends 9.2 H3N2 Infection Treatment Growth Drivers 9.3 H3N2 Infection Treatment Market Challenges 9.4 H3N2 Infection Treatment Market Restraints 10 Global Market Forecast 10.1 H3N2 Infection Treatment Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of H3N2 Infection Treatment by Type (2022-2027) 10.1.2 Global Forecasted Revenue of H3N2 Infection Treatment by Type (2022-2027) 10.2 H3N2 Infection Treatment Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of H3N2 Infection Treatment by Application (2022-2027) 10.2.2 Global Forecasted Revenue of H3N2 Infection Treatment by Application (2022-2027) 10.3 H3N2 Infection Treatment Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of H3N2 Infection Treatment by Region (2022-2027) 10.3.2 Global Forecasted Revenue of H3N2 Infection Treatment by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global H3N2 Infection Treatment Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global H3N2 Infection Treatment Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global H3N2 Infection Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers H3N2 Infection Treatment Covered in This Study Table 5. Global H3N2 Infection Treatment Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global H3N2 Infection Treatment Sales Share by Manufacturers (2016-2021) Table 7. Global H3N2 Infection Treatment Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global H3N2 Infection Treatment Revenue Share by Manufacturers (2016-2021) Table 9. Global Market H3N2 Infection Treatment Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers H3N2 Infection Treatment Manufacturing Sites and Area Served Table 11. Manufacturers H3N2 Infection Treatment Product Type Table 12. Global H3N2 Infection Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global H3N2 Infection Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H3N2 Infection Treatment as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global H3N2 Infection Treatment Sales by Region (2016-2021) & (K Pcs) Table 16. Global H3N2 Infection Treatment Sales Market Share by Region (2016-2021) Table 17. Global H3N2 Infection Treatment Revenue by Region (2016-2021) & (US$ Million) Table 18. North America H3N2 Infection Treatment Sales by Country (2016-2021) & (K Pcs) Table 19. North America H3N2 Infection Treatment Sales Market Share by Country (2016-2021) Table 20. North America H3N2 Infection Treatment Revenue by Country (2016-2021) & (US$ Million) Table 21. North America H3N2 Infection Treatment Revenue Market Share by Country (2016-2021) Table 22. Europe H3N2 Infection Treatment Sales by Country (2016-2021) & (K Pcs) Table 23. Europe H3N2 Infection Treatment Sales Market Share by Country (2016-2021) Table 24. Europe H3N2 Infection Treatment Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe H3N2 Infection Treatment Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific H3N2 Infection Treatment Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific H3N2 Infection Treatment Sales Market Share by Region (2016-2021) Table 28. Asia Pacific H3N2 Infection Treatment Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific H3N2 Infection Treatment Revenue Market Share by Region (2016-2021) Table 30. Latin America H3N2 Infection Treatment Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America H3N2 Infection Treatment Sales Market Share by Country (2016-2021) Table 32. Latin America H3N2 Infection Treatment Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America H3N2 Infection Treatment Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa H3N2 Infection Treatment Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa H3N2 Infection Treatment Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa H3N2 Infection Treatment Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa H3N2 Infection Treatment Revenue Market Share by Country (2016-2021) Table 38. Global H3N2 Infection Treatment Sales (K Pcs) by Type (2016-2021) Table 39. Global H3N2 Infection Treatment Sales Market Share by Type (2016-2021) Table 40. Global H3N2 Infection Treatment Revenue (Million US$) by Type (2016-2021) Table 41. Global H3N2 Infection Treatment Revenue Share by Type (2016-2021) Table 42. Global H3N2 Infection Treatment Price (USD/Pcs) by Type (2016-2021) Table 43. Global H3N2 Infection Treatment Sales (K Pcs) by Application (2016-2021) Table 44. Global H3N2 Infection Treatment Sales Market Share by Application (2016-2021) Table 45. Global H3N2 Infection Treatment Revenue (Million US$) by Application (2016-2021) Table 46. Global H3N2 Infection Treatment Revenue Share by Application (2016-2021) Table 47. Global H3N2 Infection Treatment Price (USD/Pcs) by Application (2016-2021) Table 48. AIMM Therapeutics B.V. Corporation Information Table 49. AIMM Therapeutics B.V. Description and Business Overview Table 50. AIMM Therapeutics B.V. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. AIMM Therapeutics B.V. H3N2 Infection Treatment Product Table 52. AIMM Therapeutics B.V. Recent Developments/Updates Table 53. Aphios Corporation Corporation Information Table 54. Aphios Corporation Description and Business Overview Table 55. Aphios Corporation H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Aphios Corporation H3N2 Infection Treatment Product Table 57. Aphios Corporation Recent Developments/Updates Table 58. Crucell N.V. Corporation Information Table 59. Crucell N.V. Description and Business Overview Table 60. Crucell N.V. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Crucell N.V. H3N2 Infection Treatment Product Table 62. Crucell N.V. Recent Developments/Updates Table 63. CSL Limited Corporation Information Table 64. CSL Limited Description and Business Overview Table 65. CSL Limited H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. CSL Limited H3N2 Infection Treatment Product Table 67. CSL Limited Recent Developments/Updates Table 68. Glide Pharmaceutical Technologies Limited Corporation Information Table 69. Glide Pharmaceutical Technologies Limited Description and Business Overview Table 70. Glide Pharmaceutical Technologies Limited H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Glide Pharmaceutical Technologies Limited H3N2 Infection Treatment Product Table 72. Glide Pharmaceutical Technologies Limited Recent Developments/Updates Table 73. ILiAD Biotechnologies, LLC Corporation Information Table 74. ILiAD Biotechnologies, LLC Description and Business Overview Table 75. ILiAD Biotechnologies, LLC H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. ILiAD Biotechnologies, LLC H3N2 Infection Treatment Product Table 77. ILiAD Biotechnologies, LLC Recent Developments/Updates Table 78. Inovio Pharmaceuticals, Inc. Corporation Information Table 79. Inovio Pharmaceuticals, Inc. Description and Business Overview Table 80. Inovio Pharmaceuticals, Inc. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. Inovio Pharmaceuticals, Inc. H3N2 Infection Treatment Product Table 82. Inovio Pharmaceuticals, Inc. Recent Developments/Updates Table 83. Johnson & Johnson Corporation Information Table 84. Johnson & Johnson Description and Business Overview Table 85. Johnson & Johnson H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 86. Johnson & Johnson H3N2 Infection Treatment Product Table 87. Johnson & Johnson Recent Developments/Updates Table 88. Medicago Inc. Corporation Information Table 89. Medicago Inc. Description and Business Overview Table 90. Medicago Inc. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 91. Medicago Inc. H3N2 Infection Treatment Product Table 92. Medicago Inc. Recent Developments/Updates Table 93. MedImmune, LLC Corporation Information Table 94. MedImmune, LLC Description and Business Overview Table 95. MedImmune, LLC H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 96. MedImmune, LLC H3N2 Infection Treatment Product Table 97. MedImmune, LLC Recent Developments/Updates Table 98. Mucosis B.V. Corporation Information Table 99. Mucosis B.V. Description and Business Overview Table 100. Mucosis B.V. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 101. Mucosis B.V. H3N2 Infection Treatment Product Table 102. Mucosis B.V. Recent Developments/Updates Table 103. NanoViricides, Inc. Corporation Information Table 104. NanoViricides, Inc. Description and Business Overview Table 105. NanoViricides, Inc. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 106. NanoViricides, Inc. H3N2 Infection Treatment Product Table 107. NanoViricides, Inc. Recent Developments/Updates Table 108. Novavax, Inc. Corporation Information Table 109. Novavax, Inc. Description and Business Overview Table 110. Novavax, Inc. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 111. Novavax, Inc. H3N2 Infection Treatment Product Table 112. Novavax, Inc. Recent Developments/Updates Table 113. OPKO Health, Inc. Corporation Information Table 114. OPKO Health, Inc. Description and Business Overview Table 115. OPKO Health, Inc. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 116. OPKO Health, Inc. H3N2 Infection Treatment Product Table 117. OPKO Health, Inc. Recent Developments/Updates Table 118. Sarepta Therapeutics, Inc. Corporation Information Table 119. Sarepta Therapeutics, Inc. Description and Business Overview Table 120. Sarepta Therapeutics, Inc. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 121. Sarepta Therapeutics, Inc. H3N2 Infection Treatment Product Table 122. Sarepta Therapeutics, Inc. Recent Developments/Updates Table 123. Takeda Pharmaceutical Company Limited Corporation Information Table 124. Takeda Pharmaceutical Company Limited Description and Business Overview Table 125. Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 126. Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Product Table 127. Takeda Pharmaceutical Company Limited Recent Developments/Updates Table 128. Visterra, Inc. Corporation Information Table 129. Visterra, Inc. Description and Business Overview Table 130. Visterra, Inc. H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 131. Visterra, Inc. H3N2 Infection Treatment Product Table 132. Visterra, Inc. Recent Developments/Updates Table 133. Zydus Cadila Healthcare Limited Corporation Information Table 134. Zydus Cadila Healthcare Limited Description and Business Overview Table 135. Zydus Cadila Healthcare Limited H3N2 Infection Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 136. Zydus Cadila Healthcare Limited H3N2 Infection Treatment Product Table 137. Zydus Cadila Healthcare Limited Recent Developments/Updates Table 138. Production Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. H3N2 Infection Treatment Distributors List Table 141. H3N2 Infection Treatment Customers List Table 142. H3N2 Infection Treatment Market Trends Table 143. H3N2 Infection Treatment Growth Drivers Table 144. H3N2 Infection Treatment Market Restraints Table 145. Global H3N2 Infection Treatment Sales Forecast by Type (2022-2027) & (K Pcs) Table 146. Global H3N2 Infection Treatment Sales Market Share Forecast by Type (2022-2027) Table 147. Global H3N2 Infection Treatment Revenue Forecast by Type (2022-2027) & (US$ Million) Table 148. Global H3N2 Infection Treatment Revenue Market Share Forecast by Type (2022-2027) Table 149. Global H3N2 Infection Treatment Sales Forecast by Application (2022-2027) & (K Pcs) Table 150. Global H3N2 Infection Treatment Sales Market Share Forecast by Application (2022-2027) Table 151. Global H3N2 Infection Treatment Revenue Forecast by Application (2022-2027) & (US$ Million) Table 152. Global H3N2 Infection Treatment Revenue Market Share Forecast by Application (2022-2027) Table 153. Global H3N2 Infection Treatment Sales Forecast by Region (2022-2027) & (K Pcs) Table 154. Global H3N2 Infection Treatment Sales Market Share Forecast by Region (2022-2027) Table 155. Global H3N2 Infection Treatment Revenue Forecast by Region (2022-2027) & (US$ Million) Table 156. Global H3N2 Infection Treatment Revenue Market Share Forecast by Region (2022-2027) Table 157. Research Programs/Design for This Report Table 158. Key Data Information from Secondary Sources Table 159. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of H3N2 Infection Treatment Figure 2. Global H3N2 Infection Treatment Market Share by Type in 2020 & 2027 Figure 3. APP-309 Product Picture Figure 4. Aspidasept Product Picture Figure 5. C-05 Product Picture Figure 6. CR-8020 Product Picture Figure 7. Others Product Picture Figure 8. Global H3N2 Infection Treatment Market Share by Application in 2020 & 2027 Figure 9. Clinic Figure 10. Hospital Figure 11. Others Figure 12. Global H3N2 Infection Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global H3N2 Infection Treatment Market Size 2016-2027 (US$ Million) Figure 14. Global H3N2 Infection Treatment Sales 2016-2027 (K Pcs) Figure 15. Global H3N2 Infection Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. H3N2 Infection Treatment Sales Share by Manufacturers in 2020 Figure 17. Global H3N2 Infection Treatment Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest H3N2 Infection Treatment Players: Market Share by Revenue in 2020 Figure 19. H3N2 Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global H3N2 Infection Treatment Sales Market Share by Region (2016-2021) Figure 21. Global H3N2 Infection Treatment Sales Market Share by Region in 2020 Figure 22. Global H3N2 Infection Treatment Revenue Market Share by Region (2016-2021) Figure 23. Global H3N2 Infection Treatment Revenue Market Share by Region in 2020 Figure 24. U.S. H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E H3N2 Infection Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of H3N2 Infection Treatment by Type (2016-2021) Figure 49. Sales Market Share of H3N2 Infection Treatment by Application (2016-2021) Figure 50. Sales Market Share of H3N2 Infection Treatment by Application in 2020 Figure 51. Revenue Share of H3N2 Infection Treatment by Application (2016-2021) Figure 52. Revenue Share of H3N2 Infection Treatment by Application in 2020 Figure 53. Manufacturing Cost Structure of H3N2 Infection Treatment Figure 54. Manufacturing Process Analysis of H3N2 Infection Treatment Figure 55. H3N2 Infection Treatment Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

AIMM Therapeutics B.V. Aphios Corporation Crucell N.V. CSL Limited Glide Pharmaceutical Technologies Limited ILiAD Biotechnologies, LLC Inovio Pharmaceuticals, Inc. Johnson & Johnson Medicago Inc. MedImmune, LLC Mucosis B.V. NanoViricides, Inc. Novavax, Inc. OPKO Health, Inc. Sarepta Therapeutics, Inc. Takeda Pharmaceutical Company Limited Visterra, Inc. Zydus Cadila Healthcare Limited